Clinical trial
Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
NCT00130039 · Asan Medical Center, Other · Completed
Key facts
| NCT number | NCT00130039 |
|---|---|
| Title | Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II |
| Official title | Trial for Efficacy and Safety of Cilostazol on the Progression of Symptomatic Intracranial Stenosis Comparing Clopidogrel |
| Acronym | TOSS-2 |
| Lead sponsor | Asan Medical Center, Other |
| Collaborators | Korea Otsuka International Asia Arab Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cerebral Infarction, Atherosclerosis |
| Intervention type | Drug |
| Interventions | clopidogrel, Cilostazol |
| Enrollment | 457 |
| Start date | Aug 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Aug 15, 2005 |
| Last update posted | Jan 12, 2010 |
| Countries | Hong Kong, Philippines, South Korea, Thailand |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: